Treatment with ionizing radiation (IR) can lead to the accumulation of tumor-infiltrating regulatory T cells (T reg cells) and subsequent resistance of tumors to radiotherapy. Here we focused on the contribution of the epidermal mononuclear phagocytes Langerhans cells (LCs) to this phenomenon because of their ability to resist depletion by high-dose IR. We found that LCs resisted apoptosis and rapidly repaired DNA damage after exposure to IR. In particular, we found that the cyclin-dependent kinase inhibitor CDKN1A (p21) was overexpressed in LCs and that Cdkn1a −/− LCs underwent apoptosis and accumulated DNA damage following IR treatment. Wild-type LCs upregulated major histocompatibility complex class II molecules, migrated to the draining lymph nodes and induced an increase in T reg cell numbers upon exposure to IR, but Cdkn1a −/− LCs did not. Our findings suggest a means for manipulating the resistance of LCs to IR to enhance the response of cutaneous tumors to radiotherapy.
Ionizing radiation (IR) is a powerful therapeutic arm used to eliminate tumor mass, and considerable effort has been devoted to elucidating the molecular events that lead to IR resistance in cancer cells 1 . DNA double-strand breaks (DSBs) are the most cytotoxic type of DNA lesion induced upon the exposure of cells to IR. The formation of DSBs triggers a global response to DNA damage that culminates in the phosphorylation of numerous substrates in the surrounding chromatin, including the histone variant H2AX (γ-H2AX). These DNA modifications facilitate the recruitment of DNA-damage-response proteins that include inhibitors of the cell-cycle checkpoint to halt further accumulation of damage; nucleases and polymerases to directly excise and repair damaged DNA; and an array of anti-apoptotic molecules to allow adequate time for repair and survival after exposure to IR 1 . Several mechanisms have been shown to promote the resistance of tumors to IR-induced cell death that include the overexpression of proteins involved in the neutralization of molecular free oxygen increased activation of the TRP53 checkpoint, enhanced DNA-repair mechanisms, and increased abundance of anti-apoptotic molecules such as BID, BAK and Bcl-x L (ref. 1) .
Although radiotherapy is classically predicated on direct antitumor toxicity 2 , an emerging body of evidence suggests that IR can promote anti-tumor immune responses through the release of tumor antigens, the activation of antigen-presenting cells (APCs) and T cell polarization [3] [4] [5] [6] . Such findings are consistent with the success of checkpoint-blockade inhibitors in improving adaptive immune responses induced by the IR-mediated increase in tumor antigens 4, 7, 8 . In contrast to those observations, several studies have reported that IR also leads to the accumulation of tumor-infiltrating regulatory T cells (T reg cells) that can dampen anti-tumor immunity 2, 9 . Thus, the potential use of radiotherapy as part of a tumor-immunotherapy regimen needs to take into account the effect of IR-induced tumor-protective T reg cells 10 .
Langerhans cells (LCs) are a largely quiescent subset of mononuclear phagocytes that populate the epidermis. LCs share features with dendritic cells (DCs) and macrophages 11 and, similar to macrophages, are recruited to the skin during embryogenesis and self-renew independently of circulating precursor cells, throughout life 12 . Although macrophages are among the hematopoietic cells most resistant to IR, LCs are on the extreme end of this spectrum, as they are able to resist lethal doses of IR 13 . A clinically relevant consequence of the resistance of LCs to IR is the graft-versus-host disease that occurs following the transplantation of hematopoietic stem cells 14 , whereby recipient LCs that survive irradiation continue to present host antigens to allogeneic T cells and thereby exacerbate allogeneic rejection by donor T cells. Such observations suggest that LCs are able to present host antigens and to prime and expand allogeneic effector T cell populations in vivo despite prior exposure to lethal doses of IR. The mechanisms responsible for the resistance of LCs to IR, however, have not yet been elucidated.
The ability of LCs to resist high-dose IR suggests their potential contribution to the modulation of T cell responses in IR-treated cutaneous tumors. However, a correlation between the radioresistance of LCs and the outcome in tumor growth has not been shown. Notably, a comprehensive study of the molecular and cellular mechanisms that confer IR resistance onto LCs has not been undertaken 15 . It is possible that the unique ontogeny and homeostasis of the LC compartment might contribute to the underlying IR-resistance mechanisms of LCs and might even suggest mechanisms used by other lineages 13, 15 . Hence, understanding the mechanisms that promote the resistance of LCs to IR might have diverse implications for the identification of unique molecular events that modulate IR-induced immune responses in macrophages and self-renewing populations.
In this study, we sought to examine the phenomenon of the resistance of LCs to IR at the cellular and molecular level. By using a combination of DNA-damage and proliferation assays, radiation chimeras, antigen targeting and adoptive-transfer strategies, we found that LCs resisted depletion and damage by IR on the basis of their intrinsic expression of the cyclin-dependent kinase inhibitor CDKN1A (p21). We also found that IR potentiated the LC-mediated generation of T reg cells and that the accumulation of T reg cells was directly correlated with skin-tumor growth.
RESULTS

Resistance of LCs to apoptosis after IR exposure
To investigate mechanisms of resistance to IR, we generated chimeric mice by reconstituting lethally irradiated mice with bone marrow (BM) cells isolated from congenic donors; we confirmed that epidermal LCs remained exclusively of host origin for prolonged periods of time after exposure to IR 13 (Fig. 1a) . We then analyzed the single-cell dynamics of LCs following exposure to IR. In contrast to dermal DCs, LCs, although reduced in number, were never fully depleted from the skin and started to repopulate the epidermal niche around 10 d after IR treatment (Fig. 1b,c) . Moreover, these changes were accompanied by robust migration of both LCs and dermal DCs to the skin-draining lymph nodes (sdLNs) at 1-3 d after IR treatment (Fig. 1d) . We observed that DC kinetics after exposure to IR were independent of the IR dose in the range of 6-12 Gy (Supplementary Fig. 1a ), in line with published reports 16, 17 .
Changes in the density of epidermal LCs could be attributed to IR-induced apoptosis, migration to the sdLNs or a combination of both. To distinguish between those mechanisms, we used mice deficient in the chemokine receptor CCR7, a molecule required for the migration of LCs to the sdLNs 18 . We found that whereas wild-type LCs underwent the predicted decrease in absolute number in the epidermis, the number of epidermal Ccr7 −/− LCs were unaffected by 6 Gy of IR (Fig. 1e) . The persistence of Ccr7 −/− LCs in the epidermis suggested that the diminished number of epidermal LCs observed after exposure to IR might have been due to migration rather than to cell death. Flow cytometry revealed twofold greater activation of caspases in dermal DCs than in LCs (Fig. 1f) , which suggested that dermal DCs, but not LCs, underwent apoptosis following IR. The activation of caspases after IR was also true for lymph node (LN)-resident DCs (Fig. 1f) . Together these results suggested that LCs resisted A r t i c l e s npg apoptosis following exposure to IR and that the changes in the absolute number of LCs observed after exposure to IR could be attributed to the migration of LCs to the sdLNs.
Rapid repair of IR-induced DSBs by LCs
Among the many types of IR-induced damage, DNA DSBs are the most researched. DSBs are sensed and subsequently phosphorylated at the histone variant H2AX, which leads to the formation of γ-H2AX foci that span the DSBs 19 . We hypothesized that LCs would exhibit enhanced handling of genotoxic stress-induced DSBs. We therefore quantified by flow cytometry the accumulation of γ-H2AX foci in LCs and IR-sensitive DCs 24 h after exposure to IR. We found that LCs resisted the accumulation of DSBs, as indicated by a nearly complete absence of γ-H2AX foci in their nuclei 24 h after exposure to 6 Gy of IR (Fig. 2a) or 12 Gy of IR (Supplementary Fig. 1b ). This result, however, did not preclude the possibility that the failure of LCs to accumulate γ-H2AX was due to an impaired ability to sense DSBs 20, 21 . We therefore incorporated into our analysis an unbiased single-cell electrophoresisbased method of measuring DNA damage (the comet assay) 20 . In response to increasing doses of IR, LCs exhibited the least amount of DNA damage in the comet assay, relative to the damage incurred by either dermal DCs or LN-resident DCs (Fig. 2b,c) ; this indicated that LCs alone were resistant to IR-induced genotoxic stress and DSBs. Notably, as has been suggested 16 , various doses of IR treatment did not increase DNA damage or the presence of γ-H2AX foci ( Fig. 2c and Supplementary Fig. 1c ).
Due to the absence of detectable DSBs in LCs after IR, we investigated whether the repair of induced DSBs was too rapid to be detected following whole-mouse irradiation and subsequent prolonged enzymatic digestion of the skin for analysis by flow cytometry. We therefore adopted an ex vivo system in which we generated epidermal cell suspensions and treated the suspensions with 6 Gy of IR, then kept them in culture for various times before fixation and staining for γ-H2AX or analysis of DNA integrity via the comet assay.
Under these conditions, we were able to detect rapid induction and subsequent repair of DSBs by epidermal LCs (Fig. 2d,e) .
We further expanded the analysis reported above to demonstrate that Ccr7 −/− LCs were phenotypically identical to wild-type LCs, in that they rapidly repaired γ-H2AX foci within 2 h in cell culture, and that γ-H2AX foci were almost completely absent by 24 h following whole-body irradiation (Supplementary Fig. 2a) . Furthermore, we detected no substantial difference between wild-type LCs and Ccr7 −/− LCs by analysis of DNA damage with the comet assay (Supplementary Fig. 2b) .
Finally, we evaluated whether epidermal LCs were also able to resist DNA damage induced either by ultraviolet (UV) light or by the DNAdamaging agent cisplatin. In accordance with published reports 22 , exposure to UV light failed to induce phosphorylation of H2AX at any time point (Supplementary Fig. 2c ). Conversely, cisplatin, an antineoplastic agent widely used for the treatment of solid tumors, induced rapid DNA damage in epidermal LCs that was not repaired by 24 h (Supplementary Fig. 2c ). Together these data established that LCs had a robust ability to rapidly repair DNA DSBs, a property that might have contributed to their enhanced survival after IR treatment.
Overexpression of Cdkn1a and pro-survival genes by LCs
To identify potential molecular mediators that would enable LCs to withstand IR, we performed gene-expression profiling of epidermal LCs, LN-migratory LCs and LN-resident DCs. We found that LCs expressed a pro-survival gene signature both at steady state and after exposure to IR (Fig. 3a) . In particular, we noticed that expression of Cdkn1a was highest in LCs, relative to its expression in all other hematopoietic cell populations (Fig. 3b) , and that this expression, at the level of both RNA and protein, was further increased following exposure to IR (Fig. 3a,c) . Given the known roles of CDKN1A in the cellular stress response, repair of DNA DSBs and resistance to IR [23] [24] [25] [26] , we further analyzed the role of this molecule in the resistance of LCs to IR. Consequently, we repeated our initial experiments comparing Cdkn1a −/− mice and wild-type mice. Consistent with our hypothesis, LCs were significantly lower in abundance in Cdkn1a −/− mice than in wild-type mice at 3 d after exposure to IR (Fig. 3d) . Moreover, unlike wild-type LCs, Cdkn1a −/− LCs showed a significant increase in caspase activation 24 h after IR (Fig. 3e) , which indicated that Cdkn1a −/− LCs were sensitive to IR-induced apoptosis. We further evaluated whether Cdkn1a −/− LCs accumulated DSBs in response to IR. We therefore treated wild-type and Cdkn1a −/− mice with IR and, 24 h later, analyzed the accumulation of DSBs by γ-H2AX and comet assays. Cdkn1a −/− LCs showed enhanced sensitivity to IR and significant accumulation of DSBs, as demonstrated by both assays (Fig. 3f,g ). Furthermore, in contrast to DSBs in wild-type LCs, DSBs in Cdkn1a −/− LC suspensions were not repaired shortly after irradiation (Fig. 3h) . The greater abundance of DNA DSBs in Cdkn1a −/− LCs suggested the contribution of CDKN1A to the enhanced viability of LCs after exposure to IR.
CDKN1A is a known cell-cycle regulator and exercises strict control over the G1-to-S checkpoint 23 . Moreover, because LCs renew locally in the steady state, it is possible that the heightened sensitivity of Cdkn1a −/− LCs to IR exposure was due to a much greater fraction of cycling cells at steady state. To test this hypothesis, we analyzed the cycling of LCs after IR exposure by assessing the proportion of LCs that expressed the cell-cycle maker Ki67 following IR exposure. This analysis revealed that both wild-type LCs and Cdkn1a −/− LCs shared approximately the same basal proliferation, with approximately 5% of LCs in cycle (Fig. 3i) . However, Cdkn1a −/− LCs failed to undergo transient cell-cycle arrest 1 d after IR exposure, whereas wild-type LCs reduced their cycling by ~50%. These data suggested not only that the difference between wild-type LCs and Cdkn1a −/− LCs in their sensitivity to IR was independent of their quiescence status but also that Cdkn1a −/− LCs failed to engage in proper cell-cycle checkpoints following the accumulation of DSBs.
Difference in IR sensitivity among ontogenically distinct LCs
LCs derive from embryonic precursor cells that take up residence in the skin before birth, whereas dermal DCs derive from DC-restricted precursor cells that arise in the BM during adult life 13 . In addition, published results have identified a small population of BM-derived LC-like cells in the epidermis, thought to derive from circulating monocytes 27 . Since monocyte-and embryonic cell-derived LCs populate the same tissue and are exposed to the same tissue environment, comparing their radiosensitivity should elucidate the contribution of epidermal cues versus cell-intrinsic cues to the resistance of LCs to IR. We observed that monocyte-derived LCs (called 'monocytic LCs' here), characterized as MHCII + CD11b + EpCAM − cells 27 , had lower expression of CDKN1A than did embryonic cell-derived LCs (called 'embryonic LCs' here) (Fig. 4a) and accumulated a substantial frequency of DSBs upon exposure to IR (Fig. 4b,c) . These findings showed that monocytic LCs exhibited greater radio-sensitivity than did embryonic LCs.
Effect of CDKN1A mediators on LC IR sensitivity In addition to CDKN1A, members of the CDKN1A signaling pathway also have a role in resistance to IR 28 . We first focused on two candidates that were expressed at the RNA level in steady-state LCs: TRP53 (p53), which functions upstream of CDKN1A, and NFE2L2 (NRF2), which functions downstream of CDKN1A. Following exposure to IR, Trp53 transcripts decreased in abundance, whereas Nfe2l2 transcripts increased, relative to their respective steady-state abundance (Fig. 3a) . In accordance with the microarray data, Trp53 −/− LCs were able to significantly repair DNA, as assessed by the frequency of γ-H2AX foci (Fig. 5a,b ) and the comet assay (Fig. 5c,d ). DNA repair, however, did not seem to be complete and failed to resolve to the same level as that seen in wild-type LCs (Fig. 5d) . Thus, these findings suggested a partial role for TRP53 in mediating the resistance of LCs to IR. Indeed, we did not detect a substantial difference between Trp53 −/− mice and wild-type mice in their level of Cdkn1a mRNA and CDKN1A protein (Supplementary Fig. 3a,b) , which suggested that a different pathway, independent of TRP53, modulated Cdkn1a expression and consequently mediated the resistance of LCs to IR. Nfe2l2 −/− LCs accumulated significantly more DNA DSBs than did Trp53 −/− LCs, as measured by the induction of γ-H2AX foci (Fig. 5b) and comet assay (Fig. 5c,d ), while they retained the ability to repair some DNA DSBs by 2 h after exposure to IR (Fig. 5b) . Notably, both Trp53 −/− LCs and Nfe2l2 −/− LCs had significantly increased activation of caspases following exposure to IR, although it was significantly lower than that observed in Cdkn1a −/− LCs (Fig. 5e) . In accordance with the role of NFE2L2 downstream of CDKN1A, we did not detect a difference between Nfe2l2 −/− mice and wild-type mice in their Cdkn1a expression (Supplementary Fig. 3a,b) . The disparity between Nfe2l2 −/− LCs and Cdkn1a −/− LCs in DSBs and sensitivity to apoptosis suggested contributions of multiple mediators downstream of CDKN1A to the resistance of LCs to IR. We also explored the potential roles of candidate molecules outside the CDKN1A pathway, including the DNA-repair molecule ATM and the transcription factor Foxo3, in the resistance of LCs to IR. Each molecule has been linked to both resistance to IR and the myeloid response to IR 29, 30 . Neither Atm −/− LCs nor Foxo3 −/− LCs had a defect in the DNA-repair pathway (Supplementary Fig. 3c ). Although these data did not preclude the possibility of a role for alternative candidates, they did reinforce the hypothesis of a critical role for the CDKN1A pathway in mediating short-term DNA repair and survival of LCs.
Greater tumor growth in IR-treated mice
The ability of tumors to trigger immunogenic responses has been called into question in literature analyzing the use of cancer immunotherapies in potentially immunosuppressive environments 2, 9 . Our finding that LCs represented the predominant APC in the skin and sdLNs after exposure to IR prompted us to analyze the contribution of LCs to skin-tumor immunity in vivo. We devised a model system to specifically assess the effect of IR on DCs independently of its effects on local tumors. To achieve this, we pretreated mice with 6 Gy of IR and then challenged them with a subcutaneous injection of live B16 melanoma cells 12-24 h later. We found that mice pretreated with IR had significantly larger tumors than those of untreated mice (Fig. 6a) , which was associated with a greater frequency of T reg cells within the tumor and in tumor-draining LNs (Fig. 6b) . Notably, we found a similar effect when we injected the lymphoma cell-line EL4 into mice (Supplementary Fig. 4a,b) , which suggested that this effect was not mediated by the induction of melanocyte-specific T reg cells. Furthermore, we observed this effect only when we injected B16 melanoma cells shortly after IR treatment (within 12-24 h), and it was lost when we inoculated mice with tumor cells 5 weeks after IR treatment (Supplementary Fig. 4c,d) .
Analysis of the various APC populations in the sdLNs revealed a shift in the proportion of migratory APCs, with LCs representing more than 50% of all migratory DCs 12 d after IR treatment (Fig. 6c) . Notably, after exposure to IR, migratory LCs upregulated their expression of major histocompatibility complex (MHC) class II (Fig. 6d) , in further support of the possibility that these cells contributed to the generation of T reg cells. These data suggested that the increased density of LCs in the epidermis altered the anti-tumor immune response and tilted the balance in favor of the generation of tumor-protective T reg cells after exposure to IR.
LC-mediated generation of T reg cells after acute IR exposure
To establish whether the increased frequency of T reg cells after exposure to IR was a result of the shift in the proportion of LCs within sdLNs, we used a BM-chimera antibody-targeting model. We used a BM chimera system in which we transplanted Ly75 −/− BM, which is deficient in the endocytic cell-surface receptor DEC205 (expressed broadly by all DCs and LCs), into wild-type recipient mice. We permitted the resulting chimeras to recover for 2 months, at which point the only cells expressing DEC205 were IR-resistant, host-derived LCs (Supplementary Fig. 5a ). Next, we treated the BM chimeras with 6 Gy of IR 1 d before the adoptive transfer of myelin oligodendrocyte glycoprotein (MOG)-specific T cells and inoculation with DEC205-MOG-conjugated antibodies 31 . These antibodies act as carriers of MOG only to DEC205-expressing cells, which were radio-resistant LCs in this case. We then analyzed the generation of T reg cells in irradiated and non-irradiated BM chimeras 15 d later. Notably, we observed an up-to-threefold greater frequency of MOG-specific Foxp3 + T reg cells in irradiated chimeras than in their non-irradiated control counterparts (Fig. 7a) , which suggested that IR enhanced the capacity of IR-resistant LCs to generate T reg cells in sdLNs in vivo. We then sought to determine whether CDKN1A expression by LCs could modulate their ability to induce T reg cells upon exposure to IR. Thus, we generated chimeras in which we adoptively transferred Ly75 −/− BM into irradiated Cdkn1a −/− mice, so that LCs lacking CDKN1A were the only APCs that expressed DEC205 ( Supplementary Fig. 5b,c) . We found that Cdkn1a −/− LCs were much less 'potent' than wild-type LCs in driving the generation of T reg cells upon exposure to IR (Fig. 7a) . This ability of IR-treated LCs to promote T reg cells raised the possibility that persistent LCs might alter the effect of local radiotherapy on tumor survival, consistent with larger B16 tumors in mice pretreated with IR (Fig. 6a) . To evaluate the role of radio-resistant LCs in tumor survival, we transferred wild-type BM into Cdkn1a −/− mice and thereby generated mice in which LCs alone were CDKN1A deficient and were therefore susceptible to IR-induced apoptosis. After reconstitution, we exposed these chimeras to 6 Gy of IR and subsequently challenged them with B16 melanoma tumor cells. Strikingly, Cdkn1a −/− chimeras had tumors equivalent in size to those of their non-irradiated counterparts (Fig. 7b) . Furthermore, we found that tumor size in these chimeras correlated with a decreased frequency of T reg cells in tumor grafts (Fig. 7c) . This finding suggested that the accumulation of T reg cells following IR exposure was dependent on IRresistant LCs that in turn promoted tumor growth. In agreement with that hypothesis, depletion of T reg cells upon IR treatment resulted in a significantly lower tumor volume than that of non-irradiated mice (P ≤ 0.001; Supplementary Fig. 6a,b) .
In agreement with the proposal of a role for IR-treated LCs in promoting T reg cells, we found higher expression of MHC class II by IR-treated LCs than by non-IR-treated LCs (Fig. 6d) . Thus, to more explicitly link the APC function of LCs to the phenotype observed and to eliminate the possibility of an effect of other APCs or tissue stroma, we used a chimera system in which we transplanted wildtype BM or Cdkn1a −/− BM into recipients deficient in MHC class II molecules (H2 −/− host mice). In these chimeras, all hematopoietic cells expressed MHC class II except for IR-resistant LCs (data not shown). This model therefore allowed us to assess the LC-specific contribution to the generation of T reg cells after IR. We did not observe any discernible difference between irradiated H2 -/-chimeras and non-irradiated H2 -/-chimeras in B16 tumor size (Fig. 7d and   Supplementary Fig. 6c) . Moreover, LCs from H2 −/− chimeras failed to promote the population expansion of T reg cells after exposure to IR, in contrast to wild-type recipient chimeras ( Supplementary  Fig. 6d ). These data therefore suggested that IR-resistant LCs mediated the generation or population expansion of T reg cells following exposure to IR in a tumor setting and that this phenomenon was dependent on high expression of CDKN1A by LCs.
DISCUSSION
Although macrophages are among the hematopoietic cells most resistant to IR, LCs are on the extreme end of the spectrum, as they can resist a very high dose of IR 13 . Here, we were able to identify one key modulator of the resistance of LCs to IR: CDKN1A. We demonstrated, consistent with published reports 16 , that skin DCs migrated to the sdLNs in a CCR7-dependent manner following exposure to IR and that LCs singularly failed to undergo apoptosis in response to lethal doses of IR. This property was intimately connected to their unique ability to repair DNA DSBs rapidly (as early as 30 min), owing to a repertoire of genes encoding pro-survival and repair factors to enhanced expression of both in the steady state and after exposure to IR. We also found that upon exposure to IR, LCs upregulated their expression of MHC class II, migrated to the sdLNs and expanded T reg cell populations that in turn modulated tumor size.
Our analyses have identified the CDKN1A pathway as a critical regulator of the resistance of LCs to IR. CDKN1A mediates cellular stress responses, apoptosis and arrest at the G1-to-S phase of the cell cycle and has been recognized as a key modulator of resistance to chemoradiation in diverse stem cells and cancers 23 . Activation of CDKN1A has been shown to affect DNA repair, a pro-survival balance of caspase molecules, the neutralization of reactive oxygen species, and the release of key cytokines and growth factors 23 . Furthermore, CDKN1A is also able to promote survival via its phosphorylation by the kinase AKT and its subsequent ability to directly bind effector caspases and the kinase MAP3K5 (refs. 32,33 ). Here we found that CDKN1A A r t i c l e s npg contributed to the ability of LCs to resist IR via the rapid repair of DSBs, apoptosis prevention, and induction of cell-cycle arrest. Due to the myriad functions affected by CDKN1A and to technical limitations, we were unable to determine whether the resistance of LCs to IR hinged upon just one of these mechanisms. While Cdkn1a was the gene most induced following exposure to IR, our analyses identified several potential regulators of the resistance of LCs to IR. The downstream effector of CDKN1A, NFE2L2, is essential to the repair of DNA DSBs and to LC survival. However, our data were inconclusive about the role of TRP53, reported to be the main upstream regulator of the CDKN1A pathway 23 . We found that TRP53-deficient LCs were able to partially repair DNA damage, in support of published reports indicating that CDKN1A might be regulated not only by TRP53 but also by other, unidentified factors 34, 35 . Given the extensive literature on the relationship between TRP53 and CDKN1A 35, 36 , this remains an area of ongoing inquiry. Similarly, in preliminary analyses we found that ATM and Foxo3 were dispensable for short-term DNA repair after exposure to IR, but we cannot exclude the possibility of a role for their immunomodulation in the longer term 29, 30 . Likewise, analysis of molecules of the 'Bcl' family, which have a well-described effect on the survival and homeostasis of myeloid cells 37 , is needed. Thus, while CDKN1A was critical to the effect we observed here, we believe that it probably represents one critical aspect of a multifaceted DNA-damage-repair mechanism in LCs.
We found that embryonic cell-derived LCs were much more resistant to IR-induced genotoxic stress than were adult monocyte-derived LCs that reside transiently in the epidermis, which suggested that resistance to IR might be a characteristic obtained during the fetal development of these cells. Given this property, we suggest that LCs might have evolved a unique ability to tolerate diverse genotoxic threats by virtue of their development and localization in an interface tissue regularly exposed to UV light, environmental toxins and pathogens. In agreement with that proposal, LCs resist apoptosis in response to various genotoxic stressors, such as the DNA mutagen DMBA 38 and UV light 22, 39 . Similar to the results we obtained after exposure to IR, UV light-treated LCs promote the known phenomenon of UV light-induced immunosuppression 22, 39 . Furthermore, following treatment with DMBA, LCs resist DSBs and promote squamous-cell cancers 38 . A notable exception we observed, however, was the inability of LCs to fully resolve DSBs induced by cisplatin adducts. This would provide an immunological justification for the expanded use of platinum agents as IR-sensitizing chemotherapeutics directed against IR-resistant tumors 40 .
We speculate that part of the response of LCs to genotoxic stress involves an immunoinhibitory program that is permissive to skin malignancies. In fact, various reports have demonstrated that the efficacy of IR might be limited by the generation of T reg cells. We directly tackled the issue of IR-mediated immunomodulation and identified IR-treated LCs as effective promoters of T reg cells. While it has been demonstrated that T reg cells are 'preferentially' resistant to IR 41 , it has remained unclear whether T reg cell populations expand after exposure to IR. Our data demonstrated that LCs were instrumental in facilitating an increase in T reg cells in an MHC class II-dependent manner. We showed that LCs upregulated their expression of MHC II following treatment with IR and that tumor volumes in irradiated H2 -/-chimeras and non-irradiated H2 -/-chimeras were similar. Future experiments should address whether radio-resistant LCs induce de novo tumor-specific T reg cells, expand their population or recruit a pre-existing T reg cell pool. However, using a targeting strategy, we observed that irradiated LCs were superior to non-irradiated LCs in their ability to induce MOG-specific T reg cells, which suggested that IR might substantially alter the intrinsic capacity of LCs to induce tolerance. Notably, given that our aim was to elucidate the immunomodulatory effects of IR, we did not address the direct effects of IR on tumors, which have already been reported broadly 42 .
It is critical to understand the apparently opposing effects of IR, given its clinical pervasiveness; approximately half of all patients with cancer will undergo radiation therapy at some point in the course of their disease 43 . Here we found that tumors might resist IR treatment by a mechanism involving LC-mediated accumulation of T reg cells. T reg cells might negatively affect anti-tumor immune responses via blockade of tumor-specific effector cells or, independently of antigen specificity, via the expression of regulatory cytokines such as interleukin 10 (ref. 44) . Conversely, depletion of T reg cells, achieved by injection of diphtheria toxin into mice expressing the gene encoding the diphtheria toxin receptor under control of the Foxp3 promoter obviates this effect and promotes slower tumor growth 9 . We speculate that IR-induced immunity is not skin-antigen specific but instead is tumor specific, as we recapitulated our findings with an EL4 lymphoma model. This is consistent with a model in which the direct activation of LCs by IR promotes the presentation of tumor antigens and the induction of tumor-specific effector T reg cells. The temporal coincidence of exposure to IR and migration of LCs seemed critical to this phenomenon, as there was no apparent T reg cell memory response in mice pretreated with IR 5 weeks before tumor inoculation.
The ability of IR to effectively promote a tolerogenic function in LCs might be associated with the generalized induction of apoptosis induced by IR 1 , although other, uncategorized mechanisms of APC modulation might exist 3, 5, 45 . An important factor to consider was our technical restriction to total-body irradiation, in lieu of stereotactic treatment. It is possible that local treatment results in diminished LC-driven generation of T reg cells; this highlights the importance of dose constraints in sparing healthy tissues.
Our study contributes to an expanding literature linking cellular checkpoint-and stress-related molecules to the immunological function of APCs such as DCs and macrophages. For example, published work has identified a role for low-dose irradiation in macrophage polarization in the context of a mouse melanoma model, in which IR-conditioned macrophages exhibit anti-tumor effects via the inhibition of angiogenesis and the enhanced generation of reactive oxygen species 46 . Other studies have also shown that DNA-repair molecules such as ATM can modulate the ability of APCs to polarize T cells into the T H 17 subset of helper T cells by releasing interleukin 23 (ref. 30 ). Here we demonstrated that LCs were programmed to resist depletion by IR and rapidly mitigated DNA DSBs in a CDKN1A-dependent manner. Furthermore, LCs potently generated T reg cells in response to IR treatment that promoted tumor growth. The induction of T reg cells after exposure to IR is probably dependent on tissue-specific signals and the type of APCs that inhabit the tissues treated with IR. Thus, understanding tissue-specific responses to IR might help in the design of novel rationale strategies to avoid the resistance of tumors to IR. Our work suggests a critical means by which the generation of T reg cells could potentially be blocked through the sensitization of local radio-resistant LCs to IR and thereby promote enhanced tumor responses to radiotherapy.
METHODS
Methods and any associated references are available in the online version of the paper.
